MAPT and Alzheimer disease: The NIA–AA framework used for the diagnosis of AD is undoubtedly centered on amyloid β and tau, in which a deterministic chain of events leads from Aβ and then tau deposition to neurodegeneration and progressive cognitive impairment [237].